A 6-month follow-up of disability, quality of life, and depressive and anxiety symptoms in pediatric migraine with magnesium prophylaxis

Gordana Kovačević, Dejan Stevanović, Dragana Bogićević, Dimitrije Nikolić, Slavica Ostojić, Biljana Vučetić Tadić, Blažo Nikolić, Ivana Bosiočić, Nikola Ivančević, Kristina Jovanović,

Magnesium Research · 2017 · 11 citations · 0 references

Concepts

Abstract

) = 8.91 (1.59, 49.29), p = 0.001). Considering the KIDSCREEN-27, scores for physical and psychological well-being and social support domain significantly increased from baseline to end-point (p≤0.01). After 6 months of magnesium prophylaxis, disability due to migraine significantly decreased, whereas physical and psychosocial well-being improved. Children also reported fewer anxiety and depressive symptoms. More follow-up and randomized controlled clinical trials are needed to propose clinical recommendations for magnesium prophylaxis in pediatric migraine.